|
|
 |
MONA GUPTA PARTNER TELEPHONE: 215-567-2010.
EXTENSION 160
FAX: 215-751-1142
mgupta@crbcp.com
|
Ms. Gupta has extensive experience with complex and high-stakes patent litigation, especially pharmaceutical patent litigation involving the Hatch-Waxman Act, both at the district court and appellate court levels. Ms. Gupta's litigation practice is mainly focused on representing generic drug companies in patent infringement cases involving Abbreviated New Drug Applications (ANDAs) that include a Paragraph IV certification to the Orange Book listed patents for brand-name drugs. She has been involved in all phases of ANDA patent litigation, from the preparation of notice letters, pleadings to discovery, trial and appeal. She has extensive experience with "Markman" claim construction hearings, summary judgment hearings, preliminary injunction hearings and the corresponding briefing process, as well as substantial appellate brief writing experience. She is a member of the firm's ANDA Litigation Team.
Genzyme v. Pentech Pharmaceuticals, Inc. (N.D. Ill. 2008), represent generic manufacturer in ANDA litigation on Hectorol® (doxercalciferol)
In re '318 Patent Litigation (D. Del. 2005), represented generic manufacturer in ANDA litigation involving the Alzheimer's drug Razadyne®/Reminyl® (galanthamine)
Roche Palo Alto v. Apotex, Inc. (N.D. Cal. 2005), represented generic manufacturer concerning an ophthalmic NSAID solution for reducing pain and inflammation of the eyes, Acular LS ® (ketorolac tromethamine)
American Med. Techs., Inc. v. Velopex Int'l., Inc. (S.D. Tx. 2005), represented defendant in a patent infringement suit involving dental device
Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc. (S.D.N.Y. 2003), represented generic in ANDA litigation on anti-platelet medication Plavix® (clopidogrel bisulphate).
Apotex, Inc. v. Eon Labs Manufacturing., Inc. (S.D.N.Y. 2002), represented patentee in litigation involving generic anti-organ rejection medication cyclosporin
Syntex (U.S.A.), LLC and Allergan, Inc. v. Apotex, Inc. (N.D. Cal. 2001), represented ANDA applicant involving an ophthalmic NSAID solution Acular® (ketorolac tromethamine).
Thomas Med., Inc. v. Guidant Corp. (E.D. Pa. 2001), represented plaintiff in a patent infringement suit involving medical device
Pennsylvania
United States Supreme Court
United States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Third Circuit
United States District Court for the Eastern District of Pennsylvania
High-Stakes ANDA Pharmaceutical Litigation and Paragraph IV Challenges, The Legal Intelligencer IP Supplement, April 2008
Examining Phillips: Is it a Step Towards Predictable Construction Claims? The Patent Lawyer, Winter 2005
Pennsylvania SuperLawyer by Philadelphia Magazine, 2006-2008
Pennsylvania Rising Star by Philadelphia Magazine, 2005
Top 50 Women Lawyers in Pennsylvania by Philadelphia Magazine, 2007
Drexel University: B. S. Engineering magna cum laude
Rutgers University: J.D.
RETURN TO TOP OF PAGE
|
|
MONA GUPTA partner
INDUSTRIES SERVED
Computer Systems
Medical Devices
Pharmaceuticals
Telecommunications
ADMITTED TO PRACTICE
Pennsylvania
United States District Court for the Eastern District of Pennsylvania
United States Court of Appeals for the Federal Circuit
United States Court of Appeals for the Third Circuit
AWARDS & RECOGNITION
Named Pennsylvania SuperLawyer by Philadelphia Magazine, 2006 - 2008
Named Pennsylvania Rising Star by Philadelphia Magazine, 2005
Top 50 Women Lawyers in Pennsylvania by Philadelphia Magazine, 2007
EDUCATIONAL
BACKGROUND
Drexel University: B.S Engineering magna cum laude
Rutgers University: J.D.
|
|
